News
>
Bhart Biotech
Bhart Biotech
Advertisement
As India awaits EUL nod for Covaxin, WHO says ‘decision may take longer time’
Bharat Biotech's Covaxin shows 77.8 % efficacy in phase 3 data trial: Sources
1152747
1
0
topics
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
NEWS ON ONE CLICK
)
)
